1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90. [PubMed] [Google Scholar]
2. Munich (Germany): World Gastroenterology Organization (WGO); 2009. World Gastroenterology Organization (WGO). World Gastroenterology Organization Global Guideline: Irritable Bowel Syndrome: A Global Perspective; p. 20. [Google Scholar]
3. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral. Gut. 2000;46:78–82. [PMC free article] [PubMed] [Google Scholar]
4. Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil. 2010;16:389–400. [PMC free article] [PubMed] [Google Scholar]
5. Kotwal MR, Durrani HA, Shah SN. Chronic colonic diarrhoea in North-West India. (A clinical study with special reference to the syndrome of irritable colon) J Indian Med Assoc. 1978;70:77–80. [PubMed] [Google Scholar]
6. Makharia GK, Verma AK, Amarchand R, Goswami A, Singh P, Agnihotri A, et al. Prevalence of irritable bowel syndrome: A community based study from northern India. J Neurogastroenterol Motil. 2011;17:82–7. [PMC free article] [PubMed] [Google Scholar]
7. Kellow JE, Eckersley GM, Jones M. Enteric and central contributions to intestinal dysmotility in irritable bowel syndrome. Dig Dis Sci. 1992;37:168–74. [PubMed] [Google Scholar]
8. Snape WJ, Jr, Carlson GM, Matarazzo SA, Cohen S. Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the irritable bowel syndrome. Gastroenterology. 1977;72:383–7. [PubMed] [Google Scholar]
9. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, et al. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992;67:725–31. [PubMed] [Google Scholar]
10. van Wijk HJ, Smout AJ, Akkermans LM, Roelofs JM, ten Thije OJ. Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol. 1992;27:99–102. [PubMed] [Google Scholar]
11. Evans PR, Bak YT, Shuter B, Hoschl R, Kellow JE. Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci. 1997;42:2087–93. [PubMed] [Google Scholar]
12. Welgan P, Meshkinpour H, Ma L. Role of anger in antral motor activity in irritable bowel syndrome. Dig Dis Sci. 2000;45:248–51. [PubMed] [Google Scholar]
13. Leahy A, Besherdas K, Clayman C, Mason I, Epstein O. Abnormalities of the electrogastrogram in functional gastrointestinal disorders. Am J Gastroenterol. 1999;94:1023–8. [PubMed] [Google Scholar]
14. Kumar D, Wingate DL. The irritable bowel syndrome: A paroxysmal motor disorder. Lancet. 1985;2:973–7. [PubMed] [Google Scholar]
15. Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology. 1990;98(5 Pt 1):1208–18. [PubMed] [Google Scholar]
16. Schmidt T, Hackelsberger N, Widmer R, Meisel C, Pfeiffer A, Kaess H. Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol. 1996;31:581–9. [PubMed] [Google Scholar]
17. f*ckudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998;42:845–9. [PMC free article] [PubMed] [Google Scholar]
18. Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. Dysmotility of the small intestine in irritable bowel syndrome. Gut. 1988;29:1236–43. [PMC free article] [PubMed] [Google Scholar]
19. Kellow JE, Langeluddecke PM, Eckersley GM, Jones MP, Tennant CC. Effects of acute psychologic stress on small-intestinal motility in health and the irritable bowel syndrome. Scand J Gastroenterol. 1992;27:53–8. [PubMed] [Google Scholar]
20. Cann PA, Read NW, Brown C, Hobson N, Holdsworth CD. Irritable bowel syndrome: Relationship of disorders in the transit of a single solid meal to symptom patterns. Gut. 1983;24:405–11. [PMC free article] [PubMed] [Google Scholar]
21. Lu CL, Chen CY, Chang FY, Lee SD. Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: An oriental study. Clin Sci (Lond) 1998;95:165–9. [PubMed] [Google Scholar]
22. Rogers J, Henry MM, Misiewicz JJ. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut. 1989;30:634–41. [PMC free article] [PubMed] [Google Scholar]
23. Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology. 1988;94(5 Pt 1):1150–6. [PubMed] [Google Scholar]
24. f*ckudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med. 1987;151:373–85. [PubMed] [Google Scholar]
25. Bueno L, Fioramonti J, Ruckebusch Y, Frexinos J, Coulom P. Evaluation of colonic myoelectrical activity in health and functional disorders. Gut. 1980;21:480–5. [PMC free article] [PubMed] [Google Scholar]
26. Horikawa Y, Mieno H, Inoue M, Kajiyama G. Gastrointestinal motility in patients with irritable bowel syndrome studied by using radiopaque markers. Scand J Gastroenterol. 1999;34:1190–5. [PubMed] [Google Scholar]
27. Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990;98(5 Pt 1):1187–92. [PubMed] [Google Scholar]
28. Munakata J, Naliboff B, Harraf F, Kodner A, Lembo T, Chang L, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology. 1997;112:55–63. [PubMed] [Google Scholar]
29. Schmulson M, Chang L, Naliboff B, Lee OY, Mayer EA. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol. 2000;95:152–6. [PubMed] [Google Scholar]
30. Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception. Gastroenterology. 1998;115:1263–71. [PubMed] [Google Scholar]
31. Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut. 2002;51(Suppl 1):i67–71. [PMC free article] [PubMed] [Google Scholar]
32. Ruigómez A, García Rodríguez LA, Panés J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: Influence of comorbidities. Clin Gastroenterol Hepatol. 2007;5:465–9. [PubMed] [Google Scholar]
33. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535–44. [PubMed] [Google Scholar]
34. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol. 2007;42(Suppl 17):41–7. [PubMed] [Google Scholar]
35. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. BMJ. 1997;314:779–82. [PMC free article] [PubMed] [Google Scholar]
36. Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41:844–9. [PubMed] [Google Scholar]
37. Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591–6. [PMC free article] [PubMed] [Google Scholar]
38. Barbara G, Cremon C, Pallotti F, De Giorgio R, Stanghellini V, Corinaldesi R. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48(Suppl 2):S95–7. [PubMed] [Google Scholar]
39. Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523–6. [PMC free article] [PubMed] [Google Scholar]
40. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702. [PubMed] [Google Scholar]
41. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122:1778–83. [PubMed] [Google Scholar]
42. Törnblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 2002;123:1972–9. [PubMed] [Google Scholar]
43. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203–9. [PMC free article] [PubMed] [Google Scholar]
44. Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53:1443–54. [PubMed] [Google Scholar]
45. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial. Ann Intern Med. 2006;145:557–63. [PubMed] [Google Scholar]
46. Kim DY, Camilleri M. Serotonin: A mediator of the brain-gut connection. Am J Gastroenterol. 2000;95:2698–709. [PubMed] [Google Scholar]
47. Yeo A, Boyd P, Lumsden S, Saunders T, Handley A, Stubbins M, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut. 2004;53:1452–8. [PMC free article] [PubMed] [Google Scholar]
48. Sikander A, Rana SV, Sinha SK, Prasad KK, Arora SK, Sharma SK, et al. Serotonin transporter promoter variant: Analysis in Indian IBS patients and control population. J Clin Gastroenterol. 2009;43:957–61. [PubMed] [Google Scholar]
49. Houghton LA, Foster JM, Whorwell PJ. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther. 2000;14:775–82. [PubMed] [Google Scholar]
50. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial. Lancet. 2000;355:1035–40. [PubMed] [Google Scholar]
51. Miwa J, Echizen H, Matsueda K, Umeda N. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001;63:188–94. [PubMed] [Google Scholar]
52. Wood JD. Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol. 2002;35(1 Suppl):S11–22. [PubMed] [Google Scholar]
53. Mayer EA, Naliboff BD, Chang L. Basic pathophysiologic mechanisms in irritable bowel syndrome. Dig Dis. 2001;19:212–8. [PubMed] [Google Scholar]
54. Vivinus-Nébot M, Dainese R, Anty R, Saint-Paul MC, Nano JL, Gonthier N, et al. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: Role of barrier defects and mast cells. Am J Gastroenterol. 2012;107:75–81. [PubMed] [Google Scholar]
55. Cryan JF, O’Mahony SM. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil. 2011;23:187–92. [PubMed] [Google Scholar]
56. Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842–8. [PubMed] [Google Scholar]
57. Nakai A, Kumakura Y, Boivin M, Rosa P, Diksic M, D’Souza D, et al. Sex differences of brain serotonin synthesis in patients with irritable bowel syndrome using alpha-[11C] methyl-L-tryptophan, positron emission tomography and statistical parametric mapping. Can J Gastroenterol. 2003;17:191–6. [PubMed] [Google Scholar]
58. Jones MP, Dilley JB, Drossman D, Crowell MD. Brain-gut connections in functional GI disorders: Anatomic and physiologic relationships. Neurogastroenterol Motil. 2006;18:91–103. [PubMed] [Google Scholar]
59. Waring WS, Chui M, Japp A, Nicol EF, Ford MJ. Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome. J Clin Gastroenterol. 2004;38:658–63. [PubMed] [Google Scholar]
60. Lee CT, Chuang TY, Lu CL, Chen CY, Chang FY, Lee SD. Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: A hospital-based oriental study. Dig Dis Sci. 1998;43:1794–9. [PubMed] [Google Scholar]
61. Jarrett ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci. 2003;48:386–94. [PubMed] [Google Scholar]
62. Naliboff BD, Derbyshire SW, Munakata J, Berman S, Mandelkern M, Chang L, et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med. 2001;63:365–75. [PubMed] [Google Scholar]
63. Olden KW. Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol. 2012;5:69–100. [PMC free article] [PubMed] [Google Scholar]
64. Jackson JL, O’Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis. Am J Med. 2000;108:65–72. [PubMed] [Google Scholar]
65. Ford AC. Management of irritable bowel syndrome. Minerva Gastroenterol Dietol. 2009;55:273–87. [PubMed] [Google Scholar]
66. Chang L, Harris LA. Pathophysiology of IBS and Serotonin Signaling. Medscape. 2004. [Last accessed on 2015 Jul 25]. Available from: http://www.medscape.org/viewarticle/463521_3 .
67. Patacchioli FR, Angelucci L, Dellerba G, Monnazzi P, Leri O. Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS) J Endocrinol Invest. 2001;24:173–7. [PubMed] [Google Scholar]
68. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: A review. Am J Ther. 2003;10:61–7. [PubMed] [Google Scholar]
69. Posserud I, Agerforz P, Ekman R, Björnsson ES, Abrahamsson H, Simrén M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut. 2004;53:1102–8. [PMC free article] [PubMed] [Google Scholar]
70. Longstreth GF. Irritable bowel syndrome. In: Manu P, editor. Functional Somatic Syndrome. Cambridge: University Press; 1998. pp. 55–73. [Google Scholar]
71. Lydiard RB. Irritable bowel syndrome, anxiety, and depression: What are the links? J Clin Psychiatry. 2001;62(Suppl 8):38–45. [PubMed] [Google Scholar]
72. Farting MJ. Fortnightly review: Irritable bowel, irritable body, or irritable brain? BMJ. 1995;310:171–5. [PMC free article] [PubMed] [Google Scholar]
73. Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med. 1995;25:1259–67. [PubMed] [Google Scholar]
74. Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001;55:716–20. [PMC free article] [PubMed] [Google Scholar]
75. Karling P, Danielsson A, Adolfsson R, Norrback KF. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterol Motil. 2007;19:896–904. [PubMed] [Google Scholar]
76. Blomhoff S, Spetalen S, Jacobsen MB, Malt UF. Phobic anxiety changes the function of brain-gut axis in irritable bowel syndrome. Psychosom Med. 2001;63:959–65. [PubMed] [Google Scholar]
77. Padhy SK, Misra S, Sarkar S, Panigrahi M, Bung G. Comparison of psychiatric comorbidity in individuals with IBS and non-ulcer dyspepsia. Ind Psychiatry J. 2015 [In press] [PMC free article] [PubMed] [Google Scholar]
78. Pata C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol. 2002;97:1780–4. [PubMed] [Google Scholar]
79. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2002;123:425–32. [PubMed] [Google Scholar]
80. Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, et al. The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology. 2011;140:1943–51. [PMC free article] [PubMed] [Google Scholar]
81. Alonso C, Guilarte M, Vicario M, Ramos L, Ramadan Z, Antolín M, et al. Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology. 2008;135:163–172.e1. [PubMed] [Google Scholar]
82. Farnam A, Somi MH, Sarami F, Farhang S. Five personality dimensions in patients with irritable bowel syndrome. Neuropsychiatr Dis Treat. 2008;4:959–62. [PMC free article] [PubMed] [Google Scholar]
83. Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med. 2000;62:309–17. [PubMed] [Google Scholar]
84. Wrzesinska MA, Kocur J. The assessment of personality traits and coping style level among the patients with functional dyspepsia and irritable bowel syndrome. Psychiatr Pol. 2008;42:709–17. [PubMed] [Google Scholar]
85. Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol. 2003;9:2293–9. [PMC free article] [PubMed] [Google Scholar]
86. Porcelli P, Bagby RM, Taylor GJ, De Carne M, Leandro G, Todarello O. Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. Psychosom Med. 2003;65:911–8. [PubMed] [Google Scholar]
87. Surdea-Blaga T, Baban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol. 2012;18:616–26. [PMC free article] [PubMed] [Google Scholar]
88. Drossman DA, Chang L, Schneck S, Blackman C, Norton WF, Norton NJ. A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity. Dig Dis Sci. 2009;54:1532–41. [PubMed] [Google Scholar]
89. Gomborone J, Dewsnap P, Libby G, Farthing M. Abnormal illness attitudes in patients with irritable bowel syndrome. J Psychosom Res. 1995;39:227–30. [PubMed] [Google Scholar]
90. Lackner JM, Quigley BM, Blanchard EB. Depression and abdominal pain in IBS patients: The mediating role of catastrophizing. Psychosom Med. 2004;66:435–41. [PubMed] [Google Scholar]
91. Chitkara DK, van Tilburg MA, Blois-Martin N, Whitehead WE. Early life risk factors that contribute to irritable bowel syndrome in adults: A systematic review. Am J Gastroenterol. 2008;103:765–74. [PMC free article] [PubMed] [Google Scholar]
92. Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: Relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001;134(9 Pt 2):917–25. [PubMed] [Google Scholar]
93. Koloski NA, Talley NJ, Boyce PM. A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: The role of other psychosocial variables. Digestion. 2005;72:86–96. [PubMed] [Google Scholar]
94. Videlock EJ, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M, et al. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology. 2009;137:1954–62. [PMC free article] [PubMed] [Google Scholar]
95. White DL, Savas LS, Daci K, Elserag R, Graham DP, Fitzgerald SJ, et al. Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther. 2010;32:551–61. [PMC free article] [PubMed] [Google Scholar]
96. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and the Gastrointestinal Tract V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2001;280:G519–24. [PubMed] [Google Scholar]
97. Drossman DA. The role of psychosocial factors in gastrointestinal illness. Scand J Gastroenterol Suppl. 1996;221:1–4. [PubMed] [Google Scholar]
98. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992;33:825–30. [PMC free article] [PubMed] [Google Scholar]
99. Vanuytsel T, van Wanrooy S, Vanheel H, Vanormelingen C, Verschueren S, Houben E, et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut. 2014;63:1293–9. [PubMed] [Google Scholar]
100. Iorio N, Makipour K, Palit A, Friedenberg FK. Post-traumatic stress disorder is associated with irritable bowel syndrome in African Americans. J Neurogastroenterol Motil. 2014;20:523–30. [PMC free article] [PubMed] [Google Scholar]
101. Hu YJ, Wang YD, Tan FQ, Yang WX. Regulation of paracellular permeability: Factors and mechanisms. Mol Biol Rep. 2013;40:6123–42. [PubMed] [Google Scholar]
102. Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: Importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol. 2015;12:36–49. [PubMed] [Google Scholar]
103. Mendeloff AI, Monk M, Siegel CI, Lilienfeld A. Illness experience and life stresses in patients with irritable colon and with ulcerative colitis. An epidemiologic study of ulcerative colitis and regional enteritis in Baltimore, 1960-1964. N Engl J Med. 1970;282:14–7. [PubMed] [Google Scholar]
104. Fava GA, Pavan L. Large bowel disorders. I. Illness configuration and life events. Psychother Psychosom. 1976-1977;27:93–9. [PubMed] [Google Scholar]
105. Drossman DA, Sandler RS, McKee DC, Lovitz AJ. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology. 1982;83:529–34. [PubMed] [Google Scholar]
106. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988;95:701–8. [PubMed] [Google Scholar]
107. Creed F, Craig T, Farmer R. Functional abdominal pain, psychiatric illness, and life events. Gut. 1988;29:235–42. [PMC free article] [PubMed] [Google Scholar]
108. Dinan TG, O’Keane V, O’Boyle C, Chua A, Keeling PW. A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease. Acta Psychiatr Scand. 1991;84:26–8. [PubMed] [Google Scholar]
109. Levy RL, Cain KC, Jarrett M, Heitkemper MM. The relationship between daily life stress and gastrointestinal symptoms in women with irritable bowel syndrome. J Behav Med. 1997;20:177–93. [PubMed] [Google Scholar]
